What is PharmPak?
PharmPak Inc., operating since 1983, specializes in providing ready-to-dispense medications, a service designed to significantly improve patient compliance and therapeutic results. The company offers comprehensive solutions including bulk medication repackaging and the supply of both prescription and over-the-counter drugs. Key features of their service include unit-dose blister-pack dispensing and customized labeling, catering to a diverse clientele that spans family planning centers, surgery centers, senior care facilities, and various health departments. PharmPak's commitment to quality customer service and adherence to federal regulations ensures a streamlined experience for healthcare providers.
How much funding has PharmPak raised?
PharmPak has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for PharmPak?
The substantial capital infusion, indicated by the $150K in total funding and the recent $150K strategic investment, positions PharmPak for significant expansion and operational enhancement. This late-stage funding suggests a focus on scaling its proven model, potentially through broader market penetration, technological advancements in its dispensing and repackaging services, or strategic acquisitions. The company is well-poised to further solidify its role in improving medication management across various healthcare settings.
See full PharmPak company page
